Compare Gold Fields Limited (GFI) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gold Fields Limited vs Zimmer Biomet Holdings Inc — how do they compare? Gold Fields Limited trades at $36.82 (market cap $31.87B), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Gold Fields Limited is the larger of the two by market cap, and Gold Fields Limited pays the higher dividend (6%). Which is the better fit depends on your goals — on Pluang, investors hold Gold Fields Limited for 49 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| GFI | ZBH | |
|---|---|---|
Market Cap | $31.87B | $16.95B |
Volume | 4,169,651 | 2,505,240 |
Sector | Basic Materials | Health |
52-Week High | $61.52 | $103.98 |
52-Week Low | $31.25 | $79.58 |
Typical Hold Time | 49 Days | 89 Days |
Enterprise Value | $32.47B | $24.02B |
Dividend Yield | 6% | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gold Fields (GFI) trades at $35.86, up 2.31% today, amid a bearish technical signal and mixed earnings history. The stock shows strong fundamentals with a P/E of 7.3, net income margin of 38.66%, and robust cash flow growth, while recent news highlights a rejected $27 billion takeover bid for Northern Star, creating investor uncertainty.
The outlook is balanced: valuation metrics and profitability support upside toward the $52.75 analyst target, but near-term risks include acquisition-related volatility and technical weakness. Investors should weigh high ROE and cash returns against execution risks from expansion efforts.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% on the day, with a bearish technical signal but strong recent earnings beats. The company reported Q2 2026 EPS of $2.07, exceeding expectations, and maintains a solid gross profit margin of 69.87%. Revenue growth is steady, reaching $8.23B in 2025, though net income margin has moderated. Analyst consensus is a 'Buy' with a $103.11 price target, indicating potential upside from current levels.
The outlook for ZBH is cautiously optimistic, supported by earnings momentum and a diversified medical technology portfolio. Key risks include rising debt levels, with debt-to-asset ratio increasing to 32.57% in 2025, and competitive pressures in the healthcare sector. Institutional ownership trends show continued interest, but investors should monitor margin sustainability and capital expenditure efficiency.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gold Fields Limited
Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is primarily involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.
Read more on GFI →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
